Bioniche

( "Bioniche"; TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today provided an update on its Phase III clinical

WN.com - Articles related to Two new books look at Castro through friends' eyes 2009

Xconomy Sciences Inc. ( "Bioniche"; TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today provided an update on its Phase III clinical biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like

WN.com - Articles related to Organizing for Halloween 2009

Two are furthest along, one from a Minnesota company called Epitopix and one by a Canadian company called Bioniche Life Sciences.

New methods aim to keep E. coli in beef lower all year 2010

The acquisition of privately held Bioniche is expected to increase Mylan's earnings in the first year after closing.

Travelers, BofA Drag on Dow 2010

Donors are superovulated with a hormone called Follicle Stimulating Hormone (FSH) which is available in several forms (Folltropin: Bioniche, F-Tropin: Austin, Ovagen: ICP).

Archive 2008-01-01 CC 2008

Industry Canada's Industrial Technologies Office formerly Technology Partnerships Canada has contributed to the development of Bioniche's mycobacterial cell wall technologies by means of a C$9.6 million loan to be repaid by Bioniche from sales.

unknown title 2011

Under the licensing agreement, Bioniche received an up-front payment of July 2009, and became eligible to receive an additional US$110 million in milestone payments.

unknown title 2011

Milestones are announced as they are achieved and, with its exclusive manufacturing supply contract, Bioniche provides clinical trial material and will also receive a net-sales-based revenue stream upon product approval.

unknown title 2011

"They're all related," said Graham McRae, president and CEO of Bioniche, the Belleville, Ont., company developing the vaccine.

CBC | Top Stories News 2011

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide.

unknown title 2011